Clinical Trial

Healing of Apicomarginal Defects Using Autograft or Allograft With Collagen Membrane

Not Yet Recruiting
View on ClinicalTrials.gov →
Record status
This record was last updated February 17, 2026 (before its estimated May 1, 2026 completion). Its status may not reflect the trial's current state.
Summary
Apicomarginal defects, which connect apical and marginal bone loss, are difficult to manage surgically due to their limited regenerative potential. Guided tissue regeneration using grafts and collagen membranes may improve outcomes, but the comparative effectiveness of autografts and allografts in these defects is not well established. This randomized clinical trial at PGIDS Rohtak will evaluate 36 patients undergoing endodontic microsurgery, assigning them to either autograft or allograft combined with a bioresorbable collagen membrane. Clinical and CBCT-based radiographic healing will be monitored over 12 months. The study aims to determine whether allografts can achieve bone regeneration comparable to autografts, offering a less invasive option for treating apicomarginal defects.
Trial Details
NCT Number NCT07412067
Lead Sponsor Postgraduate Institute of Dental Sciences Rohtak
Collaborators: Post Graduate Institute of Dental Sciences
Conditions Apicomarginal Defects
Enrollment 50 participants
Start Date 2026-04-01
Primary Completion 2026-05-01 (estimated)
Study Completion 2026-12-01 (estimated)
Updated on ClinicalTrials.gov 2026-02-17